Steven R Little Selected Research

Steven R Little Research Topics

Disease

14	Inflammation (Inflammations) 11/2021 - 09/2011
8	Neoplasms (Cancer) 08/2021 - 06/2004
4	Periodontitis 01/2022 - 11/2013
3	Dry Eye Syndromes (Dry Eye Syndrome) 01/2018 - 01/2017
3	Adenocarcinoma 06/2010 - 07/2008
2	Infections 12/2022 - 01/2014
2	Bone Resorption 01/2021 - 11/2013
2	Foreign Bodies (Foreign Body) 01/2018 - 08/2014
2	Osteoarthritis 01/2018 - 01/2018
2	Glaucoma 01/2017 - 08/2014
2	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 01/2012 - 09/2011
1	Dysbiosis 01/2022
1	Rhinosinusitis 11/2021
1	Central Nervous System Diseases (CNS Diseases) 10/2021
1	Periodontal Pocket (Periodontal Pockets) 03/2021
1	Chronic Periodontitis 03/2021
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2021
1	Pulmonary Hypertension 01/2021
1	Bone Diseases (Bone Disease) 01/2021
1	Vascular Remodeling 01/2021
1	Arthritis (Polyarthritis) 01/2020
1	Urinary Bladder Neoplasms (Bladder Cancer) 11/2018
1	Autoimmune Diseases (Autoimmune Disease) 10/2017
1	Exanthema (Rash) 10/2017
1	Hypersensitivity (Allergy) 10/2017
1	Allergic Contact Dermatitis 10/2017
1	Alveolar Bone Loss 11/2013
1	Necrosis 09/2011
1	Acquired Immunodeficiency Syndrome (AIDS) 10/2010
1	Neointima 09/2010
1	Body Weight (Weight, Body) 06/2010
1	Coronary Restenosis 04/2010
1	Breast Neoplasms (Breast Cancer) 07/2008

Drug/Important Bio-Agent (IBA)

4	Proteins (Proteins, Gene)FDA Link 01/2021 - 08/2004
3	PolymersIBA 12/2017 - 07/2008
2	Sirolimus (Rapamycin)FDA Link 01/2022 - 12/2017
2	Biocompatible Materials (Biomaterials)IBA 11/2021 - 03/2015
2	Polylactic Acid-Polyglycolic Acid CopolymerIBA 03/2021 - 01/2021
2	AntibodiesIBA 01/2021 - 01/2020
2	CytokinesIBA 12/2017 - 11/2013
2	Ophthalmic Solutions (Eye Drops)IBA 01/2017 - 08/2014
2	DystrophinIBA 01/2012 - 09/2011
2	CeramidesIBA 06/2010 - 07/2008
2	Paclitaxel (Taxol)FDA LinkGeneric 03/2009 - 07/2008
2	AntigensIBA 01/2005 - 06/2004
2	VaccinesIBA 01/2005 - 06/2004
2	EpitopesIBA 08/2004 - 06/2004
1	Pyrazinamide FDA LinkGeneric 12/2022
1	Interleukin-2 (IL2)IBA 01/2022
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2022
1	crisamicin AIBA 11/2021
1	Nasal SpraysIBA 10/2021
1	HydrogelsIBA 10/2021
1	SteroidsIBA 10/2021
1	Tumor Biomarkers (Tumor Markers)IBA 08/2021
1	Minocycline (Cyclops)FDA LinkGeneric 03/2021
1	GlutaminaseIBA 01/2021
1	Drug CombinationsIBA 01/2021
1	Insulin (Novolin)FDA Link 01/2021
1	CB-839IBA 01/2021
1	Verteporfin (Visudyne)FDA Link 01/2021
1	Interleukin-17 (Interleukin 17)IBA 01/2021
1	Interleukin-6 (Interleukin 6)IBA 01/2021
1	Synthetic DrugsIBA 01/2020
1	CollagenIBA 01/2020
1	AminesIBA 11/2018
1	Heparin (Liquaemin)FDA LinkGeneric 01/2018
1	AntioxidantsIBA 01/2018
1	Histone Deacetylase InhibitorsIBA 01/2018
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2018
1	glycolic acid (glycolate)IBA 01/2018
1	Adrenal Cortex Hormones (Corticosteroids)IBA 10/2017
1	AllergensIBA 10/2017
1	NickelIBA 10/2017
1	Chemokine CCL22IBA 01/2017
1	CationsIBA 01/2015
1	Superoxide DismutaseIBA 01/2015
1	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 01/2015
1	CopperIBA 01/2015
1	Brimonidine Tartrate (Alphagan)FDA LinkGeneric 08/2014
1	Enfuvirtide (Fuzeon)FDA Link 01/2014
1	4- (4- dihexadecylaminostyryl)- N- methylpyridium (DiA)IBA 09/2011
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2010
1	sphingosine 1-phosphate (sphingosine-1-phosphate)IBA 10/2010
1	EnzymesIBA 06/2010
1	Therapeutic UsesIBA 03/2009
1	Small Interfering RNA (siRNA)IBA 03/2009
1	N-caproylsphingosineIBA 07/2008
1	DNA (Deoxyribonucleic Acid)IBA 01/2005
1	Protein Subunit VaccinesIBA 08/2004

Therapy/Procedure

7	Therapeutics 11/2021 - 03/2009
6	Microspheres (Microsphere) 01/2022 - 08/2014
2	Ligation 01/2022 - 11/2013
2	Bioreactors (Bioreactor) 01/2018 - 01/2018
2	Stents 09/2010 - 04/2010
1	Root Planing 01/2022
1	Injections 10/2021
1	Transplantation 01/2020
1	Highly Active Antiretroviral Therapy (HAART) 01/2014
1	Subcutaneous Injections 01/2014